कोयंबटूर में 77वें स्वतंत्रता दिवस 11 मीटर ऊंचा स्टील टावर पर घुमावदार एलईडी स्क्रीन 
Elvish Yadav wins Bigg Boss OTT season 2, fans erupt in joy 
Glimpses from 77th Independence Day at Red Fort in Delhi 
सीएम योगी ने 77वें स्वतंत्र दिवस पर किया ध्वजारोहण 
Happy 77th Independence Day 
President raises climate change concerns in I-Day eve speech 
Next year, on August 15 from Red Fort: PM Modi’s big remark on 2024 
‘Bharat Mata is voice of every Indian’: Rahul extends wish on Independence Day 
“Selfishness of few pushed nation to tragedy of Partition”: CM Yogi Adityanath TIL Desk/Business/Washington/ India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to NITI Aayog CEO Amitabh Kant.
Speaking at the 14th Annual BioPharma and Healthcare Summit, he said India is now gearing up for innovation in its pharmaceutical ecosystem focusing on speedy and scaled up delivery of new vaccines and personalised medicines.
He said that India has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain. “We are planning to do complete manufacturing in India,” he said at the virtual summit organised by the USA-India Chamber of Commerce on Friday.
